Carson Wealth (CWM LLC)’s Tourmaline Bio TRML Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-71	Closed	-$3K	–	5644
2025 Q3	$3K	Buy	71 +3	+4%	+$83	﹤0.01%	4948
2025 Q2	$1K	Buy	68 +5	+8%	+$81	﹤0.01%	5081
2025 Q1	$1K	Buy	63 +48	+320%	+$769	﹤0.01%	4997
2024 Q4	$0	Buy	15 +4	+36%	+$101	﹤0.01%	5169
2024 Q3	$0	Buy	11 +2	+22%	+$33	﹤0.01%	5152
2024 Q2	$0	Buy	+9	New	+$145	﹤0.01%	4946

Carson Wealth (CWM LLC)'s TRML Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 71 shares — an estimated $3K sold.

Carson Wealth (CWM LLC) first reported a position in TRML in Q2 2024 and held it in 6 quarters. The position peaked at $3K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Carson Wealth (CWM LLC) reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 71 Tourmaline Bio shares in Q4 2025, an estimated $3K.
Carson Wealth (CWM LLC) first reported a position in Tourmaline Bio in Q2 2024 and held it in 6 quarters.
Carson Wealth (CWM LLC)'s Tourmaline Bio position peaked at $3K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.